Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | SEMA3A |
| Upstream (Parents) |
|---|
| (<<) CHST7 → SEMA3A |
| (<<) EPHB2 → SEMA3A |
| (<<) EREG → SEMA3A |
| (<<) GLS → SEMA3A |
| (<<) GNG4 → SEMA3A |
| (<<) HMOX1 → SEMA3A |
| (<<) NOTCH1 → SEMA3A |
| (<<) ORC6L → SEMA3A |
| (<<) PLCG1 → SEMA3A |
| (<<) PLCG2 → SEMA3A |
| (<<) PTK7 → SEMA3A |
| Downstream (Children) |
|---|
| SEMA3A → CREB5 (>>) |
| SEMA3A → GLRX (>>) |
| SEMA3A → HSPB1 (>>) |
| SEMA3A → KCNK1 (>>) |
| SEMA3A → PRKCQ (>>) |
| SEMA3A → SLPI (>>) |
| SEMA3A → STK11 (>>) |
| SEMA3A → SYNGR4 (>>) |
| SEMA3A → TYRO3 (>>) |
